Isracann Biosciences Inc.
OTC: ISCNF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Ajay Singh Kaila
- Headquarters
- Vancouver, Canada
- IPO year
- 2017
- Market cap
- $1.8K
- Website
- https://www.isracann.com
Loading ISCNF…
Loading profile data…Frequently asked questions about ISCNF
What does Isracann Biosciences Inc. (ISCNF) do?
Isracann Biosciences Inc., operating with its subsidiary companies, focuses on the growth and supply of medical-grade cannabis throughout Israel. The firm also dedicates resources to establishing new cultivation infrastructure. Additionally, it ships its products internationally to Germany. The company rebranded to Isracann Biosciences Inc. in O...
Where does ISCNF trade?
Isracann Biosciences Inc. (ISCNF) trades on the Other OTC.
What sector is ISCNF in?
Isracann Biosciences Inc. (ISCNF) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Isracann Biosciences Inc.?
Ajay Singh Kaila is the chief executive officer of Isracann Biosciences Inc. (ISCNF).
Where is Isracann Biosciences Inc. headquartered?
Isracann Biosciences Inc. is headquartered in Canada.
Does ISCNF pay a dividend?
Isracann Biosciences Inc. (ISCNF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ISCNF go public?
Isracann Biosciences Inc. (ISCNF) completed its initial public offering in 2017.